NVAX - NOVAVAX INC
IEX Last Trade
8.4
-0.060 -0.714%
Share volume: 34,160
Last Updated: Thu 26 Dec 2024 08:30:07 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$8.46
-0.06
-0.71%
Summary score
31%
Profitability
36%
Dept financing
25%
Liquidity
21%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2019 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
42.14%
Return on assets
-10.48%
Return on sales
-152.48%
Return on invested capital
-23.11%
Total debt ratio
104.56%
Debt ratio change over timeo
0.35%
Current Ratio
2.07%
Quick Ratio
2.05%
Cash Position Ratio
1.68%
Short-term ratios 31-Dec-2022 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
17.32%
Return on assets
-8.69%
Return on sales
-125.87%
Return on invested capital
12.6%
Total debt ratio
145.91%
Debt ratio change over timeo
-1.54%
Current Ratio
0.65%
Quick Ratio
0.62%
Cash Position Ratio
0.36%
Last quarter ratios 31-Dec-2023
The data are presented for the financials results of the last quarter.
Return on equity
24.88%
Return on assets
-10.21%
Return on sales
-63.01%
Return on invested capital
18.17%
Total debt ratio
139.88%
Debt ratio change over time
6.7%
Current Ratio
0.7%
Quick Ratio
0.67%
Cash Position Ratio
0.35%
Performance ratios (change over 4 years) 31-Dec-2019 - 31-Dec-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-214.45%
Return on assets
-145.08%
Return on sales
-339.37%
Return on invested capital
-63.65%
Total debt ratio
34.77%
Debt ratio change over time
0.35%
Current Ratio
-3.19%
Quick Ratio
-3.24%
Cash Position Ratio
-3.04%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NVAX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 42.14% | 10.2% | 35.82% | 7.59% |
| Return on assets | -10.48% | 2.89% | 3.31% | 5.76% |
| Return on sales | -152.48% | 29.84% | 34.06% | 41.2% |
| Return on invested capital | -23.11% | 3.06% | 5.78% | 20.17% |
| Profitability | 25% | 40% | 63% | 80% |
| Total debt ratio | 104.56% | 91.31% | 89.91% | 26.84% |
| Debt ratio change over time | 0.35% | 295.05% | -10.03% | 1.11% |
| Dept financing | 25% | 47% | 21% | 7% |
| Current Ratio | 0.65% | 0.92% | 2.61% | 5.44% |
| Quick Ratio | 0.62% | 0.8% | 2.24% | 4.68% |
| Cash Position Ratio | 0.36% | 0.31% | 1.72% | 2.92% |
| Liquididy | 47% | 18% | 34% | 75% |
| Short-term ratios | NVAX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 17.32% | 9.95% | 27.09% | 4.01% |
| Return on assets | -8.69% | 2.47% | 2.17% | 3.36% |
| Return on sales | -125.87% | 24.58% | 28.87% | 32.26% |
| Return on invested capital | 12.6% | 1.71% | 5.84% | 9.7% |
| Profitability | 41% | 50% | 75% | 73% |
| Total debt ratio | 145.91% | 91.02% | 92.9% | 21.89% |
| Debt ratio change over time | -1.54% | 107.3% | -84.55% | 1.71% |
| Dept financing | 25% | 41% | 16% | 4% |
| Current Ratio | 0.65% | 0.92% | 2.61% | 5.44% |
| Quick Ratio | 0.62% | 0.8% | 2.24% | 4.68% |
| Cash Position Ratio | 0.36% | 0.31% | 1.72% | 2.92% |
| Liquididy | 9% | 11% | 39% | 75% |